Skip to content
Subscriber Only

Embryonic Stem Cell Funds Resume by U.S. After Ruling

Embryonic stem cell research, grants, and funding reviews at the National Institutes of Health have resumed after a U.S. court suspended a ban, the agency said today in a statement.

A U.S. appeals court said yesterday that the government can keep funding embryonic stem cell research, at least during the initial stages of the agency’s challenge to a federal judge’s ban on the financial support. The NIH, the federal government’s health research agency, said today it will temporarily resume its operations that had been suspended.